{"The": [0, 78], "Pharma": [1], "Proteomics": [2], "Project": [3], "is": [4], "a": [5, 22, 129], "precompetitive": [6], "biopharmaceutical": [7], "consortium": [8], "characterizing": [9], "the": [10, 85, 89, 158, 168, 198, 215, 223], "plasma": [11, 90], "proteomic": [12, 35, 102], "profiles": [13], "of": [14, 25, 56, 65, 84, 88, 132, 142, 160, 172, 206, 225], "54,219": [15], "UK": [16], "Biobank": [17], "participants.": [18], "Here": [19], "we": [20], "provide": [21], "detailed": [23], "summary": [24], "this": [26], "initiative,": [27], "including": [28], "technical": [29], "and": [30, 38, 44, 101, 125, 134, 137, 146, 181, 185, 209, 221, 229], "biological": [31, 117, 216], "validations,": [32], "insights": [33, 111], "into": [34, 112], "disease": [36], "signatures,": [37], "prediction": [39], "modelling": [40], "for": [41, 163], "various": [42], "demographic": [43], "health": [45], "indicators.": [46], "We": [47, 108, 156], "present": [48], "comprehensive": [49], "protein": [50, 173], "quantitative": [51], "trait": [52], "locus": [53], "(pQTL)": [54], "mapping": [55, 74], "2,923": [57], "proteins": [58, 151, 186], "that": [59], "identifies": [60], "14,287": [61], "primary": [62], "genetic": [63, 86, 120, 169], "associations,": [64], "which": [66], "81%": [67], "are": [68], "previously": [69], "undescribed,": [70], "alongside": [71], "ancestry-specific": [72], "pQTL": [73, 95], "in": [75], "non-European": [76], "individuals.": [77], "study": [79], "provides": [80, 197], "an": [81, 202], "updated": [82], "characterization": [83], "architecture": [87], "proteome,": [91], "contextualized": [92], "with": [93, 152, 191, 201], "projected": [94], "discovery": [96, 165], "rates": [97], "as": [98, 176], "sample": [99], "sizes": [100], "assay": [103], "coverages": [104], "increase": [105], "over": [106], "time.": [107], "offer": [109], "extensive": [110], "trans": [113], "pQTLs": [114], "across": [115, 128], "multiple": [116], "domains,": [118], "highlight": [119], "influences": [121], "on": [122, 150, 178], "ligand-receptor": [123], "interactions": [124], "pathway": [126], "perturbations": [127], "diverse": [130], "collection": [131], "cytokines": [133], "complement": [135], "networks,": [136], "illustrate": [138], "long-range": [139], "epistatic": [140], "effects": [141, 171], "ABO": [143], "blood": [144], "group": [145], "FUT2": [147], "secretor": [148], "status": [149], "gastrointestinal": [153], "tissue-enriched": [154], "expression.": [155], "demonstrate": [157], "utility": [159], "these": [161], "data": [162], "drug": [164], "by": [166], "extending": [167], "proxied": [170], "targets,": [174], "such": [175], "PCSK9,": [177], "additional": [179], "endpoints,": [180], "disentangle": [182], "specific": [183], "genes": [184], "perturbed": [187], "at": [188], "loci": [189], "associated": [190], "COVID-19": [192], "susceptibility.": [193], "This": [194], "public-private": [195], "partnership": [196], "scientific": [199], "community": [200], "open-access": [203], "proteomics": [204], "resource": [205], "considerable": [207], "breadth": [208], "depth": [210], "to": [211, 213], "help": [212], "elucidate": [214], "mechanisms": [217], "underlying": [218], "proteo-genomic": [219], "discoveries": [220], "accelerate": [222], "development": [224], "biomarkers,": [226], "predictive": [227], "models": [228], "therapeutics": [230]}